Quick Answer
Lucid Diagnostics Inc. reported Total Assets of $40.45 million for the year ending 2025.
- Lucid Diagnostics Inc. showed an increase of +31.7% in Total Assets from 2024 to 2025.
- This data is from Lucid Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $3.30 million | Q1 2022: $62.06 million | Q2 2022: $45.40 million | Q3 2022: $38.38 million | Q1 2023: $49.13 million | Q2 2023: $42.49 million | Q3 2023: $33.24 million | Q1 2024: $32.05 million | Q2 2024: $34.11 million | Q3 2024: $22.60 million | Q1 2025: $32.80 million | Q2 2025: $38.67 million | Q3 2025: $53.20 million.
- Over the full 6 years of available data (2020 to 2025), Lucid Diagnostics Inc.'s Total Assets has grown by 1,742.6%.
- Historical annual values: Fiscal year 2025: $40.45 million | Fiscal year 2024: $30.72 million | Fiscal year 2023: $27.27 million | Fiscal year 2022: $32.51 million | Fiscal year 2021: $59.00 million | Fiscal year 2020: $2.20 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: